Left Ventricular Ejection Fraction clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

    Sorry, in progress, not accepting new patients

    This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12).

    San Francisco, California and other locations

Last updated: